T1	Participants 499 544	588 patients under treatment with melarsoprol
T2	Participants 550 573	38 encephalopathy cases
T3	Participants 702 754	Nine patients were attributed to the convulsion type
T4	Participants 1322 1383	14/16 patients with encephalopathic syndrome of the coma type
T5	Participants 1412 1479	Patients with psychotic reactions or abnormal psychiatric behaviour
